Femoropopliteal Occlusive Disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2016-10-17
Clinical Trial Update: Accessing Peripheral Occluded LesiOns II (APOLO-II) [Phase 3]
The APOLO-II Phase 3 trial evaluating treatment for femoropopliteal occlusive disease has been withdrawn.